Search Result "LDL Sub-fractions"
Electronegative LDL: An Active Player in Atherogenesis or a By- Product of Atherosclerosis?
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 9 Year: 2019 Page: 1665-1679
Author(s): Andrea Rivas-Urbina,Anna Rull,Jordi Ordóñez-Llanos,José Luis Sánchez-Quesada
LDL and HDL Subfractions, Dysfunctional HDL: Treatment Options
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 6249-6255
Author(s): Antonio Garcia-Rios, Dragana Nikolic, Pablo Perez-Martinez, Jose Lopez-Miranda, Manfredi Rizzo, Ron C. Hoogeveen
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 5 Year: 2011 Page: 533-571
Author(s): Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin, Evangelos Liberopoulos
Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia
Journal: Current Vascular Pharmacology
Volume: 8 Issue: 6 Year: 2010 Page: 820-830
Author(s): Matilda Florentin, Alexadros D. Tselepis, Moses S. Elisaf, Christos V. Rizos, Dimitri P. Mikhailidis, Evangelos N. Liberopoulos
Combined Dyslipidemia: Should the Focus be LDL Cholesterol or Atherogenic Dyslipidemia?
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 3858-3868
Author(s): Manfredi Rizzo, Marcin Barylski, Ali A. Rizvi, Giuseppe Montalto, Dimitri P. Mikhailidis, Maciej Banach
Insulin Resistance, Small LDL Particles, and Risk for Atherosclerotic Disease
Journal: Current Vascular Pharmacology
Volume: 12 Issue: 4 Year: 2014 Page: 653-657
Author(s): Peter P. Toth
Cardiovascular Disease and Dyslipidemia: Beyond LDL
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 9 Year: 2011 Page: 861-870
Author(s): Janine Poss, Florian Custodis, Christian Werner, Oliver Weingartner, Michael Bohm, Ulrich Laufs
Dehydroepiandrosterone Delays LDL Oxidation In Vitro and Attenuates Several oxLDL-Induced Inflammatory Responses in Endothelial Cells
Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 6 Issue: 3 Year: 2007 Page: 174-182
Author(s): Rebeca Lopez-Marure, Claudia Huesca-Gomez, Maria de Jesus Ibarra-Sanchez, Alejandro Zentella, Oscar Perez-Mendez
Regulation of the Urokinase Receptor (uPAR) by LDL Receptor-related Protein-1 (LRP1)
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 1 Year: 2011 Page: 1962-1969
Author(s): Steven L. Gonias, Alban Gaultier, Minji Jo
“European Panel On Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses: Executive Summary
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 5 Year: 2011 Page: 531-532
Author(s): Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin, Evangelos Liberopoulos